AR060785A1 - Metodo para la proteccion de celulas de islotes de langerhans contra la apoptosis durante el proceso de obtencion de celulas donantes - Google Patents

Metodo para la proteccion de celulas de islotes de langerhans contra la apoptosis durante el proceso de obtencion de celulas donantes

Info

Publication number
AR060785A1
AR060785A1 ARP070101971A ARP070101971A AR060785A1 AR 060785 A1 AR060785 A1 AR 060785A1 AR P070101971 A ARP070101971 A AR P070101971A AR P070101971 A ARP070101971 A AR P070101971A AR 060785 A1 AR060785 A1 AR 060785A1
Authority
AR
Argentina
Prior art keywords
cells
eif5a
protection
apoptosis during
against apoptosis
Prior art date
Application number
ARP070101971A
Other languages
English (en)
Inventor
Charles A Dinarello
John E Thomspon
Original Assignee
Senesco Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senesco Technologies Inc filed Critical Senesco Technologies Inc
Publication of AR060785A1 publication Critical patent/AR060785A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Métodos para mejorar la viabilidad y recuperacion de islotes que se separan de un organo donante para su posterior transplante y más particularmente se relaciona con el uso de eIF5A de siARNs para aumentar la viabilidad de los islotes. Reivindicacion 1: Un método para inhibir las células de islotes que padecen de apoptosis durante el proceso de obtencion de donante que comprende administrar eIF5A siARN a las células de islotes de un donante de células de islotes antes del aislamiento del islote, caracterizado porque eIF5A de siARN inhibe la expresion de eIF5A en las células de islote y así inhibe la apoptosis en las células de islotes.
ARP070101971A 2006-03-20 2007-05-07 Metodo para la proteccion de celulas de islotes de langerhans contra la apoptosis durante el proceso de obtencion de celulas donantes AR060785A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78341406P 2006-03-20 2006-03-20
PCT/US2007/064424 WO2007109677A2 (en) 2006-03-20 2007-03-20 A novel method of protecting islet cells from apoptosis during the donor harvesting process

Publications (1)

Publication Number Publication Date
AR060785A1 true AR060785A1 (es) 2008-07-10

Family

ID=39680975

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101971A AR060785A1 (es) 2006-03-20 2007-05-07 Metodo para la proteccion de celulas de islotes de langerhans contra la apoptosis durante el proceso de obtencion de celulas donantes

Country Status (7)

Country Link
EP (1) EP1996707A2 (es)
JP (1) JP5543774B2 (es)
AR (1) AR060785A1 (es)
AU (1) AU2007226878A1 (es)
CA (1) CA2637137A1 (es)
IL (1) IL192388A0 (es)
WO (1) WO2007109677A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090093434A1 (en) * 2007-08-20 2009-04-09 Senesco Technologies, Inc. Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
EP1601767B1 (en) * 2003-03-05 2012-04-25 Senesco Technologies, Inc. USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
AU2004258070B2 (en) * 2003-06-06 2008-12-11 Senesco Technologies, Inc. Inhibition of apoptosis-specific elF-5A ("elF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics

Also Published As

Publication number Publication date
CA2637137A1 (en) 2007-09-27
AU2007226878A1 (en) 2007-09-27
IL192388A0 (en) 2008-12-29
EP1996707A2 (en) 2008-12-03
WO2007109677A3 (en) 2008-04-24
JP5543774B2 (ja) 2014-07-09
WO2007109677A2 (en) 2007-09-27
JP2009530418A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
SV2011003888A (es) Compuestos que expanden las celulas madre hematopoieticas
ME01699B (me) Metode za stimulaciju regeneracije jetre
BRPI0617378B8 (pt) Uso de um inibidor de il-6 para produzir uma composição farmacêutica para suprimir dano a um ilhota transplantada depois do transplante de ilhota; e aperfeiçoar a viabilidade de uma ilhota em um transplante de ilhota
Tourino et al. Tryptamine and dimethyltryptamine inhibit indoleamine 2, 3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells
CO2021006365A2 (es) Composiciones y métodos para expresar el factor ix
ES2530995T3 (es) Supresión de tumor usando perfusato placentario humano y células asesinas naturales intermediarias que provienen de placenta humana
BR112016025331A2 (pt) composições antimicrobianas
MX370149B (es) Inhibidores de la expresión o función de smad7 para usarse en el tratamiento de diabetes y/o la promoción de la supervivencia de islotes pancreáticos después del trasplante.
WO2007130612A3 (en) Method for obtaining and storing multipotent stem cells
RU2012105924A (ru) Дифференцировка эмбриональных стволовых клеток человека
WO2009050742A8 (en) Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
DK2663638T3 (da) Dyrkningsfremgangsmåde til opnåelse og opretholdelse af en ren eller beriget population af neurale pattedyrstamceller og/eller neurale progenitorceller, der in vitro er tilbøjelige til at differentiere ind i celler af oligodendrocytcellelinjen
CO6491042A2 (es) Produccion de titulos elevados de poliovirus para la produccion de vacunas
RU2013110524A (ru) Лечение диабета при помощи панкреатических эндокринных клеток-предшественников
BR112018003031A2 (pt) formulações clínicas
BR112012010750A2 (pt) sistema de armazenamento de células-tronco germinativas humanas
BR112019006865A2 (pt) caspases induzíveis e métodos para uso
CL2011002959A1 (es) Peptoide, metodo para identificar un ligando peptoide que es especificamente reconocido por las celulas autoinmunes; y su uso contre enfermedades autoinmune.
CL2020000734A1 (es) Expansión y uso de fracciones de células nk ampliadas.
CL2012002871A1 (es) Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas.
MX2022001322A (es) Bancos de células t específicas de antígeno y métodos para fabricar y usar los mismos terapéuticamente.
NZ763301A (en) Adaptation of hollow-fiber-based cell culture technology for the manufacturing of neo-islets or exosomes from stem cells
NI201100153A (es) Metodo para multiplicar tejido celular de jatropha curcas
CL2015003402A1 (es) Células madres adultas adiposas, humanas, pluripotentes: aislamiento, caracterización e implicaciones clinicas
AR060785A1 (es) Metodo para la proteccion de celulas de islotes de langerhans contra la apoptosis durante el proceso de obtencion de celulas donantes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal